Patent 7301004 was granted and assigned to Theravance on November, 2007 by the United States Patent and Trademark Office.
Disclosed are processes for preparing glycopeptide phosphonate derivatives having an amino-containing side chain. Several of the process steps are conducted in a single reaction vessel without isolation of intermediate reaction products, thereby generating less waste and improving the overall efficiency and yield of the process.